MicroRNA-based Diagnostic Identifies Squamous Lung Cancer with 96% Sensitivity
Tuesday, March 10, 2009 - 07:42
in Health & Medicine
A new study shows for the first time that a microRNA-based diagnostic test can objectively identify squamous lung cancer with 96% sensitivity, according to Harvey Pass, M.D. of the NYU Cancer Institute at NYU Langone Medical Center, one of the authors of the study published on-line ahead of print in the Journal of Clinical Oncology.
Read the whole article on Physorg
More from Physorg
Related
- Study shows microRNA-based diagnostic identifies squamous lung cancer with 96 percent sensitivityTue, 10 Mar 2009, 9:09:56 EDT
- Study shows microRNA-based diagnostic identifies squamous lung cancer with 96 percent sensitivityTue, 10 Feb 2009, 16:56:58 EST
- African American lung cancer patients may have different response to new cancer-fighting drugsWed, 7 Oct 2009, 18:11:47 EDT
- Jefferson, Ohio State team find gene signature profile for metastasisFri, 30 May 2008, 18:21:25 EDT
- Fox Chase researchers identify differences in treatments and outcomes of patients with second primary lung cancers versus those with one primary lung cancerSat, 1 Aug 2009, 14:50:39 EDT